Axsome (AXSM) Up 27.3% Since Last Earnings Report: Can It Continue?Zacks Investment Research • 03/31/22
Axsome Therapeutics to Acquire Sunosi® from Jazz Pharmaceuticals, Expanding Axsome's Leadership in NeuroscienceGlobeNewsWire • 03/28/22
Jazz Pharmaceuticals Announces Agreement to Divest Sunosi® (solriamfetol) to Axsome TherapeuticsPRNewsWire • 03/28/22
Moore Kuehn, PLLC Encourages Investors of Axsome Therapeutics, Inc. To Contact Law FirmNewsfile Corp • 03/22/22
Axsome Therapeutics to Participate in the 1st Annual Needham Virtual Neuroscience ForumGlobeNewsWire • 03/11/22
Axsome Therapeutics, Inc.'s (AXSM) CEO Herriot Tabuteau on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 03/01/22